Literature DB >> 9654140

Biochemical characterization of HIV-1 Rev as a potent activator of casein kinase II in vitro.

K Ohtsuki1, T Maekawa, S Harada, A Karino, Y Morikawa, M Ito.   

Abstract

The stimulatory effects of several DNA-binding basic proteins (histone and protamine) and HIV-1 Rev with arginine (Arg)-rich clusters on the activity of casein kinase II (CK-II) were investigated in vitro. It was found that recombinant Rev (rRev) and the synthetic oligo-fragments corresponding to the amino acid sequences of its Arg-rich cluster stimulate CK-II activity in a dose-dependent manner. The activated CK-II phosphorylates several cellular and viral proteins in HIV-1 infected human MOLT-4 cells, and also phosphorylates HIV-1 structural proteins, including recombinant reverse transcriptase (rRT). These phosphorylations are selectively inhibited by CK-II inhibitors, such as quercetin, oGA (a glycyrrhetinic acid derivative) and NCS-chrom (an enediyne containing antibiotic). The data presented here suggest that HIV-1 Rev acts as an effective potent activator of CK-II, which may be a cellular mediator promoting HIV-1 replication in virus-infected cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9654140     DOI: 10.1016/s0014-5793(98)00538-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  HIV-1 Rev transactivator: a beta-subunit directed substrate and effector of protein kinase CK2.

Authors:  F Meggio; O Marin; M Boschetti; S Sarno; L A Pinna
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

2.  Identification of a domain in human immunodeficiency virus type 1 rev that is required for functional activity and modulates association with subnuclear compartments containing splicing factor SC35.

Authors:  D M D'Agostino; T Ferro; L Zotti; F Meggio; L A Pinna; L Chieco-Bianchi; V Ciminale
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Molecular cloning of a Trypanosoma cruzi cell surface casein kinase II substrate, Tc-1, involved in cellular infection.

Authors:  Swinburne A J Augustine; Yuliya Y Kleshchenko; Pius N Nde; Siddharth Pratap; Edward A Ager; James M Burns; Maria F Lima; Fernando Villalta
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 4.  HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.

Authors:  Guangdi Li; Erik De Clercq
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-29       Impact factor: 11.056

5.  Discovering regulated networks during HIV-1 latency and reactivation.

Authors:  Sourav Bandyopadhyay; Ryan Kelley; Trey Ideker
Journal:  Pac Symp Biocomput       Date:  2006

Review 6.  Molecular analysis of early host cell infection by Trypanosoma cruzi.

Authors:  Fernando Villalta; M Nia Madison; Yuliya Y Kleshchenko; Pius N Nde; Maria F Lima
Journal:  Front Biosci       Date:  2008-05-01

7.  CK2 protein kinase is stimulated and redistributed by functional herpes simplex virus ICP27 protein.

Authors:  Maria D Koffa; Joy Kean; George Zachos; Stephen A Rice; J Barklie Clements
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

8.  Eukaryotic translation-initiation factor eIF2beta binds to protein kinase CK2: effects on CK2alpha activity.

Authors:  Franc Llorens; Nerea Roher; Francesc A Miró; Stefania Sarno; F Xavier Ruiz; Flavio Meggio; Maria Plana; Lorenzo A Pinna; Emilio Itarte
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

9.  NUCKS1, a novel Tat coactivator, plays a crucial role in HIV-1 replication by increasing Tat-mediated viral transcription on the HIV-1 LTR promoter.

Authors:  Hye-Young Kim; Byeong-Sun Choi; Sung Soon Kim; Tae-Young Roh; Jihwan Park; Cheol-Hee Yoon
Journal:  Retrovirology       Date:  2014-08-13       Impact factor: 4.602

10.  Protein kinase CK2 phosphorylation regulates the interaction of Kaposi's sarcoma-associated herpesvirus regulatory protein ORF57 with its multifunctional partner hnRNP K.

Authors:  Poonam Malik; J Barklie Clements
Journal:  Nucleic Acids Res       Date:  2004-10-14       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.